Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2020

01-06-2020 | Vasculitis | Case Report

Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease

Authors: Shigekazu Kurihara, Takefumi Kimura, Naoki Tanaka, Takumi Yanagisawa, Hiroyuki Kobayashi, Keita Kanai, Takeji Umemura, Mamoru Kobayashi, Hiromitsu Mori, Shuichi Wada

Published in: Clinical Journal of Gastroenterology | Issue 3/2020

Login to get access

Abstract

Mixed connective tissue disease (MCTD) causes multiple organ dysfunctions, such as joint swelling, pulmonary fibrosis and hypertension, and serositis, but hepatopancreatic complications are rare. Here, we report a case of young man who exhibited acute severe liver dysfunction. He also had impaired cardiac function: both ventriculi were hypokinetic, but pulmonary hypertension and pericarditis were not observed. Since his liver and cardiac function markedly improved after commencing furosemide and carperitide, we considered congestive hepatopathy due to MCTD and accompanying heart failure. Heart failure and congestive hepatopathy recurred and he was treated with diuretics and prednisolone, but he passed away by co-occurrence of acute hemorrhagic pancreatitis. Necropsy revealed chronic hepatic congestion but not accompanying autoimmune hepatitis and hepatic vasculitis. We should consider congestive hepatopathy and hemorrhagic pancreatitis as serious complications of MCTD.
Literature
1.
go back to reference Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.CrossRef Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.CrossRef
2.
go back to reference Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.CrossRef Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.CrossRef
3.
go back to reference Gunnarsson R, Aalokken TM, Molberg O, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71:1966–72.CrossRef Gunnarsson R, Aalokken TM, Molberg O, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71:1966–72.CrossRef
4.
go back to reference Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134–42.CrossRef Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134–42.CrossRef
5.
go back to reference Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98:1232–8.CrossRef Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98:1232–8.CrossRef
6.
go back to reference Amigues JM, Cantagrel A, Abbal M, et al. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055-62. Amigues JM, Cantagrel A, Abbal M, et al. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055-62.
7.
go back to reference Chan KL, Currie PJ, Seward JB, et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549–54.CrossRef Chan KL, Currie PJ, Seward JB, et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549–54.CrossRef
8.
go back to reference Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405–32.CrossRef Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405–32.CrossRef
9.
go back to reference Gelow JM, Desai AS, Hochberg CP, et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59–64.CrossRef Gelow JM, Desai AS, Hochberg CP, et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59–64.CrossRef
10.
go back to reference de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66:351–62.CrossRef de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66:351–62.CrossRef
11.
go back to reference Umemura T, Katsuyama Y, Yoshizawa K, et al. Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE. 2014;23(9):e100565.CrossRef Umemura T, Katsuyama Y, Yoshizawa K, et al. Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE. 2014;23(9):e100565.CrossRef
12.
go back to reference Marshall JB, Ravendhran N, Sharp GC. Liver disease in mixed connective tissue disease. Arch Intern Med. 1983;143:1817–8.CrossRef Marshall JB, Ravendhran N, Sharp GC. Liver disease in mixed connective tissue disease. Arch Intern Med. 1983;143:1817–8.CrossRef
13.
go back to reference Wong GW, Heneghan MA. Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):25–35.CrossRef Wong GW, Heneghan MA. Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):25–35.CrossRef
14.
go back to reference Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef
15.
go back to reference Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef
16.
go back to reference Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus. 2005;14:708–12.CrossRef Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus. 2005;14:708–12.CrossRef
17.
go back to reference Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–91.CrossRef Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–91.CrossRef
18.
go back to reference Witczak BN, Hetlevik SO, Sanner H, et al. Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study. J Rheumatol. 2019;46:739–47.CrossRef Witczak BN, Hetlevik SO, Sanner H, et al. Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study. J Rheumatol. 2019;46:739–47.CrossRef
19.
go back to reference Braun J, Sieper J, Schwarz A, et al. Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature. Rheumatol Int. 1993;13:31-6.CrossRef Braun J, Sieper J, Schwarz A, et al. Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature. Rheumatol Int. 1993;13:31-6.CrossRef
20.
go back to reference Nishida S, Fujimoto T, Usui T, et al. Mixed connective tissue disease (MCTD) with severe acute pancreatitis. Nihon Naika Gakkai Zasshi. 2001;90:1518-21.CrossRef Nishida S, Fujimoto T, Usui T, et al. Mixed connective tissue disease (MCTD) with severe acute pancreatitis. Nihon Naika Gakkai Zasshi. 2001;90:1518-21.CrossRef
21.
go back to reference Nanke Y, Kotake S, Fukasawa C, et al. A case of mixed connective tissue disease with cystic pancreatitis: successful treatment by cyclophosphamide. J Clin Rheumatol. 2001;7:131-3 Nanke Y, Kotake S, Fukasawa C, et al. A case of mixed connective tissue disease with cystic pancreatitis: successful treatment by cyclophosphamide. J Clin Rheumatol. 2001;7:131-3
22.
go back to reference Kloppel G. Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol. 2000;17:7–15. Kloppel G. Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol. 2000;17:7–15.
23.
go back to reference Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709–16.CrossRef Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709–16.CrossRef
24.
go back to reference Baysal B, Kayar Y, Ozmen A, et al. Olanzapine-induced acute pancreatitis. Turk J Gastroenterol. 2015;26:289–90.CrossRef Baysal B, Kayar Y, Ozmen A, et al. Olanzapine-induced acute pancreatitis. Turk J Gastroenterol. 2015;26:289–90.CrossRef
25.
go back to reference Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol. 2004;31:707–12. Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol. 2004;31:707–12.
26.
go back to reference Breuer GS, Baer A, Dahan D, et al. Lupus-associated pancreatitis. Autoimmun Rev. 2006;5:314–8.CrossRef Breuer GS, Baer A, Dahan D, et al. Lupus-associated pancreatitis. Autoimmun Rev. 2006;5:314–8.CrossRef
Metadata
Title
Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease
Authors
Shigekazu Kurihara
Takefumi Kimura
Naoki Tanaka
Takumi Yanagisawa
Hiroyuki Kobayashi
Keita Kanai
Takeji Umemura
Mamoru Kobayashi
Hiromitsu Mori
Shuichi Wada
Publication date
01-06-2020

Other articles of this Issue 3/2020

Clinical Journal of Gastroenterology 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.